Evidence-Based Complementary and Alternative Medicine / 2014 / Article / Tab 4

Review Article

Aspirin Resistance and Promoting Blood Circulation and Removing Blood Stasis: Current Situation and Prospectives

Table 4

Analysis of platelet aggregation rate induced by AA.

TrialsMD (95% CI) value

Chinese formula versus anti-platelet-aggregation drugs
 Tong xin luo capsule versus clopidogrel10.86 [−3.38, 5.10]0.69
 Zhilong huoxue capsule versus aspirin1−3.23 [−7.34, 0.88]0.02
 Di’ao xinxuekang capsule versus aspirin1−3.23 [−7.34, 0.88]0.02

Meta-analysis3−2.53 [−4.28, −0.78]0.005

Chinese formula plus anti-platelet-aggregation drugs versus anti-platelet-aggregation drugs
 Composite salvia dropping pill plus aspirin versus aspirin1−11.09 [−14.84, −7.34]<0.00001
 Huo xue capsule plus aspirin versus aspirin1−14.22 [−16.59, −11.85]<0.00001
 Xinnao shutong capsule plus aspirin versus aspirin1−12.58 [−14.56, −10.60]<0.00001
 Xuefu zhuyu decoction plus aspirin versus aspirin1−7.20 [−11.73, −2.67]0.002
 Ginkgo biloba extract plus aspirin versus aspirin1−2.53 [−4.53, −0.53]0.01

Meta-analysis5−9.36 [−10.48, −8.25]<0.00001

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.